LNSR
LNSR
NASDAQ · Health Care

Lensar Inc

$5.88
+0.10 (+1.73%)
As of May 16, 2:09 AM ET ·
Financial Highlights (FY 2026)
Revenue
55.73M
Net Income
-32,693,044
Gross Margin
46.4%
Profit Margin
-58.7%
Rev Growth
+18.2%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 46.4% 46.4% 57.4% 57.4%
Operating Margin -42.1% -37.9% 10.3% 10.3%
Profit Margin -58.7% -55.7% 9.6% 8.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 55.73M 47.14M 55.38M 51.89M
Gross Profit 25.86M 21.88M 31.77M 29.77M
Operating Income -23,440,024 -17,843,205 5.73M 5.35M
Net Income -32,693,044 -24,886,864 5.32M 4.60M
Gross Margin 46.4% 46.4% 57.4% 57.4%
Operating Margin -42.1% -37.9% 10.3% 10.3%
Profit Margin -58.7% -55.7% 9.6% 8.9%
Rev Growth +18.2% +18.2% +8.2% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 15.51M 16.29M
Total Equity 70.64M 78.05M
D/E Ratio 0.22 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -32,444,427 -26,069,699 9.24M 7.86M
Free Cash Flow 5.04M 4.51M